author-photo

Ravindranath Patel

30

Papers

1821

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (12)
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18).

2020 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (16)
A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (97)
A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
NATALEE: Phase III study of ribociclib (RIBO) + endocrine therapy (ET) as adjuvant treatment in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early breast cancer (EBC).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (20)
Results from a phase I study of andecaliximab in combination with FOLFIRI and bevacizumab in patients with second line metastatic colorectal cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Results from a phase I study of andecaliximab in combination with paclitaxel in patients with previously untreated metastatic breast cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Relapsed/Refractory Multiple Myeloma Patients

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)